PubRank

M A Goldberg

Author PubWeight™ 89.13‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. Proc Natl Acad Sci U S A 1996 5.69
2 Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J Biol Chem 1995 5.20
3 An essential role for p300/CBP in the cellular response to hypoxia. Proc Natl Acad Sci U S A 1996 4.57
4 Post-transcriptional regulation of vascular endothelial growth factor by hypoxia. J Biol Chem 1996 3.80
5 Comprehensive health care reform and managed competition. N Engl J Med 1992 3.44
6 Regulation of vascular endothelial growth factor in cardiac myocytes. Circ Res 1995 1.75
7 Angiogenesis is induced in a rabbit model of hindlimb ischemia by naked DNA encoding an HIF-1alpha/VP16 hybrid transcription factor. Circulation 2000 1.70
8 Red blood cell regeneration induced by subcutaneous recombinant erythropoietin: iron-deficient erythropoiesis in iron-replete subjects. Blood 1993 1.62
9 Neuropsychological correlates of white-matter lesions in healthy elderly subjects. A threshold effect. Arch Neurol 1992 1.59
10 Efficacy of CT in distinguishing small-bowel obstruction from other causes of small-bowel dilatation. AJR Am J Roentgenol 1994 1.51
11 Effect of inflammatory cytokines on hypoxia-induced erythropoietin production. Blood 1992 1.51
12 Regulation of vascular endothelial growth factor expression by insulin-like growth factor I. Diabetes 1997 1.45
13 Hypoxia-inducible protein binding to vascular endothelial growth factor mRNA and its modulation by the von Hippel-Lindau protein. J Biol Chem 1996 1.43
14 Efficacy of different dosing regimens for recombinant human erythropoietin in a simulated perisurgical setting: the importance of iron availability in optimizing response. Am J Med 1994 1.43
15 Modulators of protein kinase C inhibit hypoxia-induced erythropoietin production. Exp Hematol 1993 1.40
16 Hepatic hemangiomas and malignant tumors: improved differentiation with heavily T2-weighted conventional spin-echo MR imaging. Radiology 1994 1.37
17 Inhibition of hypoxia-inducible factor 1 activation by carbon monoxide and nitric oxide. Implications for oxygen sensing and signaling. J Biol Chem 1999 1.33
18 Cyclophosphamide cardiotoxicity: an analysis of dosing as a risk factor. Blood 1986 1.30
19 Spontaneous radiographic disappearance of cerebral cysticercosis: three cases. Neurology 1983 1.18
20 Enzyme-linked immunosorbent assay for the diagnosis of cerebral cysticercosis. J Clin Microbiol 1984 1.15
21 Participation of hemoglobins A and F in polymerization of sickle hemoglobin. J Biol Chem 1977 1.15
22 Identification and characterization of a low oxygen response element involved in the hypoxic induction of a family of Saccharomyces cerevisiae genes. Implications for the conservation of oxygen sensing in eukaryotes. J Biol Chem 2001 1.11
23 The validity of hysterical signs and symptoms. J Nerv Ment Dis 1986 1.10
24 Hypoxia up-regulates the activity of a novel erythropoietin mRNA binding protein. J Biol Chem 1991 1.08
25 A quantitative MRI study of vascular dementia. Neurology 1992 1.08
26 Regulatory elements of the erythropoietin gene. Blood 1991 1.05
27 Regulation of vascular endothelial growth factor by hypoxia and its modulation by the von Hippel-Lindau tumor suppressor gene. Kidney Int 1997 1.04
28 Sequencing of the human vascular endothelial growth factor (VEGF) 3' untranslated region (UTR): conservation of five hypoxia-inducible RNA-protein binding sites. Biochim Biophys Acta 1997 0.99
29 MGA2 is involved in the low-oxygen response element-dependent hypoxic induction of genes in Saccharomyces cerevisiae. Mol Cell Biol 2001 0.98
30 US, CT, and MRI of primary and secondary liver lymphoma. J Comput Assist Tomogr 1994 0.97
31 The effect of erythrocyte membrane preparations on the polymerization of sickle hemoglobin. J Biol Chem 1981 0.97
32 A new immunologic test for CNS cysticercosis. Neurology 1984 0.95
33 The treatment of Kleine-Levin syndrome with lithium. Can J Psychiatry 1983 0.95
34 Effects of subcutaneous recombinant human erythropoietin in normal subjects: development of decreased reticulocyte hemoglobin content and iron-deficient erythropoiesis. J Lab Clin Med 1994 0.95
35 Indeterminate adrenal mass in patients with cancer: evaluation at PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 1995 0.94
36 Coexistent Acanthamoeba keratitis and herpetic keratitis. Arch Ophthalmol 1997 0.91
37 Cerebral toxoplasmosis and lymphoma in AIDS: perfusion MR imaging experience in 13 patients. Radiology 1998 0.91
38 Misdiagnosis of hysteria. Am Fam Physician 1986 0.89
39 Medical treatment of peptic ulcer disease: is it truly efficacious? Am J Med 1984 0.87
40 Histocompatibility antigens in systemic lupus erythematosus. Arthritis Rheum 1976 0.87
41 In vitro and in vivo effects of polyhexamethylene biguanide against herpes simplex virus infection. Cornea 1997 0.85
42 Microbial changes in the ocular environment with contact lens wear. CLAO J 1992 0.84
43 Percutaneous management of hilar biliary malignancies with metallic endoprostheses: results, technical problems, and causes of failure. Radiographics 1993 0.84
44 Complete remission in acute promyelocytic leukemia despite persistence of abnormal bone marrow promyelocytes during induction therapy: experience in 34 patients. Blood 1988 0.83
45 Cerebral blood flow changes with acute cocaine intoxication: clinical correlations with SPECT, CT, and MRI. NIDA Res Monogr 1994 0.83
46 Regulation of erythropoietin production. Exp Hematol 1993 0.83
47 Heterotopic ossification mimicking acute arthritis after neurologic catastrophes. Arch Intern Med 1977 0.82
48 Failed metallic biliary stents: causes and management of delayed complications. Clin Radiol 1994 0.82
49 Neurologic complications of cocaine abuse. Neurology 1988 0.82
50 Bone and joint infection with Arizona hinshawii: report of a case and a review of the literature. Am J Med Sci 1976 0.82
51 Regulation of the erythropoietin gene. Stem Cells 1993 0.82
52 HIV-1 suppresses erythropoietin production in vitro. Exp Hematol 1993 0.81
53 Is heparin administration necessary during induction chemotherapy for patients with acute promyelocytic leukemia? Blood 1987 0.81
54 Percutaneous ethanol injection for the treatment of hepatic tumors: indications, mechanism of action, technique, and efficacy. AJR Am J Roentgenol 1995 0.80
55 Presumed epithelial cyst in the anterior chamber following refractive keratotomy. J Refract Corneal Surg 1995 0.80
56 Predicting progress and pitfalls in 1996. Discussion. Bus Health 1996 0.80
57 Sickle cell arthropathy: analysis of synovial fluid in sickle cell anemia with joint effusion. South Med J 1973 0.80
58 Effect of topical povidone-iodine versus topical ofloxacin on experimental Staphylococcus keratitis. Graefes Arch Clin Exp Ophthalmol 2000 0.79
59 Affective disorders and circadian rhythms. Can J Psychiatry 1986 0.79
60 Serum erythropoietin levels in patients receiving intensive chemotherapy and radiotherapy. Blood 1990 0.78
61 Inhibition of synaptosomal protein synthesis by neurotransmitter substances. Brain Res 1972 0.78
62 Implementing global telemedicine: experience with 1097 cases from the Middle East to the USA. J Telemed Telecare 1996 0.78
63 Physiology of erythropoietin production. Semin Hematol 1994 0.77
64 Cerebral cysticercosis: an overview. Bull Clin Neurosci 1983 0.77
65 Recurrent corneal ulcerations associated with smokeable methamphetamine abuse. Am J Ophthalmol 1996 0.77
66 Cerebrospinal fluid IgE and the diagnosis of cerebral cysticercosis. Bull Los Angeles Neurol Soc 1981 0.77
67 Intention myoclonus in Huntington's disease. Bull Los Angeles Neurol Soc 1976 0.77
68 Naproxen sodium: comparative efficacy and tolerability of two dosages for pain after joint surgery. Orthopedics 1988 0.77
69 Protein synthesis in isolated rat brain mitochondria and nerve endings. Brain Res 1971 0.76
70 Regulation of the erythropoietin gene. Adv Exp Med Biol 1989 0.76
71 State-of-the-art MR imaging of the adrenal gland. Radiographics 1994 0.76
72 Effects of red cell membrane on the polymerization of sickle hemoglobin. Blood Cells 1982 0.76
73 Effect of calcium phosphate materials on multipotent mesenchymal cells from exfoliated deciduous teeth (SHED cells) in vitro. Bull Exp Biol Med 2013 0.75
74 Use of recombinant human erythropoietin in allogeneic bone marrow transplant donor/recipient pairs. Blood 1994 0.75
75 Erythropoietin therapy in cancer patients. Oncology (Williston Park) 1991 0.75
76 It's getting easier for employers to sue you. Med Econ 1997 0.75
77 In vitro labeling patterns of synaptosomal proteins. Proc Soc Exp Biol Med 1973 0.75
78 Get ready for the IRS's newest doctor shakedown. Med Econ 1997 0.75
79 How the new tax law affects your practice. Dent Manage 1986 0.75
80 Wallstent metallic biliary endoprosthesis: MR imaging characteristics. Radiology 1992 0.75
81 Neurologic complications of drug therapy. Prim Care 1984 0.75
82 Protein turnover and axonal flow in beta-beta'-iminodipropionitrile induced axonal dystrophy. J Neurochem 1977 0.75
83 Metabolism of dimethoxymethyl phenobarbital (eterobarb) in patients with epilepsy. Ann Neurol 1979 0.75
84 Enhancement of diphenylhydantoin binding by lipid extraction. J Pharmacol Exp Ther 1976 0.75
85 Phenytoin, phospholipids, and calcium. Neurology 1977 0.75
86 Why your buy-sell agreement is a time bomb. Med Econ 1991 0.75
87 Gadolinium-DTPA enhanced echoplanar MR imaging of the liver: preliminary observations. Clin Radiol 1996 0.75
88 Barbiturates in the treatment of status epilepticus. Adv Neurol 1983 0.75
89 Brain binding of anticonvulsants: carbamazepine and valproic acid. Neurology 1980 0.75
90 Stroke symposium: round table discussion. Bull Los Angeles Neurol Soc 1980 0.75
91 New tax traps in buy-sell agreement. Med Econ 1994 0.75
92 Long-term care: money's not your only worry. Med Econ 1992 0.75
93 Focal motor seizures. Arch Neurol 1977 0.75
94 Common mistakes dentists make with retirement plans. Dent Manage 1985 0.75
95 Cost control and managed competition. Bus Health 1993 0.75
96 The community competence scale as a measure of functional daily living skills. J Ment Health Adm 1991 0.75
97 Phenytoin: binding. Adv Neurol 1980 0.75
98 Binding of diphenylhydantoin to brain protein. Biochem Pharmacol 1973 0.75
99 Who needs a neurologist? Bull Clin Neurosci 1986 0.75
100 Cis elements that regulate the erythropoietin gene. Ann N Y Acad Sci 1994 0.75
101 The tough new realities of disability insurance. Med Econ 1996 0.75
102 How to know if you're getting good advice from your tax adviser. Dent Manage 1986 0.75
103 How to live with the Clinton taxes. Med Econ 1993 0.75
104 Protein synthesis in isolated nerve endings and brain mitochondria. Neurology 1970 0.75
105 MR imaging of the liver at 1.5 T: value of signal averaging in suppressing motion artifacts. AJR Am J Roentgenol 1994 0.75
106 Has managed care made your shareholders' agreement obsolete? Med Econ 1996 0.75
107 Phenobarbital: binding. Adv Neurol 1980 0.75
108 Human brain binding of phenytoin. Neurology 1978 0.75
109 The immunology of cerebral cysticercosis. Bull Clin Neurosci 1983 0.75
110 Diphenylhydantoin binding to brain lipids and phospholipids. Biochem Pharmacol 1976 0.75
111 d-Amphetamine binding to brain lipid. Neurochem Res 1978 0.75
112 Use of diphenylhydantoin. Ann Intern Med 1973 0.75
113 Reform redux. J Health Polit Policy Law 1995 0.75
114 Stroke in protein C deficiency. Am J Med 1990 0.75
115 Practice documents. Unless they're current, they're worthless. Med Econ 1993 0.75
116 Let's keep pushing for reform. Bus Health 1995 0.75
117 A clinical pharmacology of eterobarb: a gas chromatographic--mass spectrometric study. Trans Am Neurol Assoc 1976 0.75
118 An annual legal checkup: why you need one, what it can reveal. Dent Manage 1986 0.75
119 A legal tight spot isn't a hopeless situation. Med Econ 1997 0.75